- Home
- NU vs BDX Comparison
NU vs BDX Comparison
Compare NU & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NU
- BDX
- Stock Information
- Founded
- NU 2013
- BDX 1897
- Country
- NU Brazil
- BDX United States
- Employees
- NU N/A
- BDX N/A
- Industry
- NU Finance: Consumer Services
- BDX Medical/Dental Instruments
- Sector
- NU Finance
- BDX Health Care
- Exchange
- NU Nasdaq
- BDX Nasdaq
- Market Cap
- NU 58.5B
- BDX 58.9B
- IPO Year
- NU 2021
- BDX 1962
- Fundamental
- Price
- NU $12.01
- BDX $172.57
- Analyst Decision
- NU Buy
- BDX Buy
- Analyst Count
- NU 9
- BDX 9
- Target Price
- NU $15.13
- BDX $235.63
- AVG Volume (30 Days)
- NU 58.0M
- BDX 3.6M
- Earning Date
- NU 05-13-2025
- BDX 05-01-2025
- Dividend Yield
- NU N/A
- BDX 2.41%
- EPS Growth
- NU 69.16
- BDX 14.07
- EPS
- NU 0.44
- BDX 5.16
- Revenue
- NU $5,645,577,000.00
- BDX $20,867,000,000.00
- Revenue This Year
- NU $171.27
- BDX $9.28
- Revenue Next Year
- NU $19.52
- BDX $4.92
- P/E Ratio
- NU $27.31
- BDX $33.43
- Revenue Growth
- NU 32.91
- BDX 5.84
- 52 Week Low
- NU $9.01
- BDX $163.33
- 52 Week High
- NU $16.15
- BDX $251.99
- Technical
- Relative Strength Index (RSI)
- NU 46.53
- BDX 38.31
- Support Level
- NU $11.72
- BDX $169.60
- Resistance Level
- NU $12.26
- BDX $176.43
- Average True Range (ATR)
- NU 0.50
- BDX 3.46
- MACD
- NU -0.16
- BDX 1.54
- Stochastic Oscillator
- NU 14.60
- BDX 40.36
About NU Nu Holdings Ltd.
Nu Holdings Ltd provides digital banking services. It offers several financial services such as Credit cards, Personal accounts, Investments, Personal Loans, Insurance, Mobile payments, Business Accounts, and Rewards. The company earns the majority of its revenue in Brazil.
About BDX Becton Dickinson and Company
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.